Convert your Lixisenatide dose
Vial
Result
Converted amount0.01 mg
Dose mass10 mcg
Concentration2,500 mcg/mL
Draw volume0.004 mL
U-100 syringe0.4 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| type 2 diabetes glycemic control | subcutaneous | 10–20 mcg | once daily |
| postprandial glucose control (add-on to basal insulin) | subcutaneous | 10–20 mcg | once daily |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 10 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 0.005 mL | 0.5 units | 200 |
| 2 mg | 2 mL | 0.01 mL | 1 units | 200 |
| 2 mg | 3 mL | 0.015 mL | 1.5 units | 200 |
| 5 mg | 1 mL | 0.002 mL | 0.2 units | 500 |
| 5 mg | 2 mL | 0.004 mL | 0.4 units | 500 |
| 5 mg | 3 mL | 0.006 mL | 0.6 units | 500 |
| 10 mg | 1 mL | 0.001 mL | 0.1 units | 1,000 |
| 10 mg | 2 mL | 0.002 mL | 0.2 units | 1,000 |
| 10 mg | 3 mL | 0.003 mL | 0.3 units | 1,000 |
Calculated for the low end of the reported type 2 diabetes glycemic control range. Change the dose in the calculator above for any other amount.
Lixisenatide at a glance
~2–3 hours
Half-life
4,858.5 Da
Molecular weight
subcutaneous
Routes
prescription
Legal status